Stock Track | GeneDx Holdings Plummets 5.09% Intraday on Multiple Analyst Price Target Cuts

Stock Track02-24

GeneDx Holdings Corp. (WGS) saw its stock price plummet 5.09% during intraday trading on Tuesday, reflecting significant selling pressure.

The sharp decline follows a series of analyst price target reductions for the company. According to research reports, BTIG lowered its target to $170 from $200, Jefferies cut its target to $150 from $180, Piper Sandler reduced its target to $130 from $160, and TD Cowen decreased its target to $135 from $165.

These coordinated downward revisions by multiple analysts suggest a reassessment of the company's near-term financial prospects, contributing to the negative investor sentiment and the stock's downward movement in the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment